Clearance Goldskin Fractional Micro Needle RF

The Goldskin Fractional Micro Needle RF is a fractional radiofrequency microneedling system for face and body that uses epidermal and dermal applications on a single platform. It delivers RF energy through micro-needles to remodel collagen and elastin, and it offers two modes - an invasive RF microneedling mode and a non-invasive RF matrix mode - with two tips, a footswitch and negative-pressure capability. The listing describes the results as quick, painless and dramatic with minimal recovery, and states it is suitable for all skin types and tones. **Key points:** - Modality: fractional RF microneedling - insulated needles deliver RF energy at depth while sparing the epidermis. - Two treatment modes in one platform: invasive RF microneedling (needle-delivered) and non-invasive RF matrix (surface RF), so the same device covers resurfacing and skin-tightening indications. - Inclusion: two tips, a footswitch and negative-pressure functionality per the listing. - Indications named: wrinkles, scars, stretch marks, enlarged pores and laxity, plus oily/acne-prone and older or thinner skin. - Skin types: the listing states suitability for all skin types and tones - the only explicit all-skin-types claim in this category sample. - Not included: the listing notes the Monaco stand pictured is sold separately, and the product is carried under 'Clearance' pricing - budget for the stand and confirm consumable/tip continuity before purchase. **Business case:** Fractional RF microneedling is the highest-revenue-per-session device type in this category because it treats wrinkles, scars and laxity with the same consumable. But clearance-priced stock signals possible end-of-life: verify tip and handpiece supply for the next 3-5 years before making it the backbone of a menu, or you risk owning a device you cannot feed. **Confidence:** High for the mechanism, modes, inclusions and all-skin-types claim - all are stated in the product record. **Evidence source:** Product listing `goldskin-fractional-radiofrequency-for-face-and-body` (id=685), fields: title, lede, what_it_is, how_it_works, who_for.

The FDA/regulatory status of the Goldskin Fractional Micro Needle RF cannot be confirmed from the current product data. The structured fields `fda_key`, `fda_label` and `fda_tone` are empty, and the listing text contains no FDA clearance, CE marking or equivalent claim. Note one important disambiguation: the word 'Clearance' in the product title refers to clearance/end-of-line sale pricing, not to FDA clearance - do not read it as regulatory status. **Key points:** - `fda_key`, `fda_label` and `fda_tone` are all empty on the product record. - 'Clearance' in the title ('Clearance Goldskin Fractional Micro Needle RF') is commercial (sale stock), not regulatory - a common and costly misreading. - No FDA, CE, Health Canada, TGA or UKCA statement appears anywhere in the listing text. - Fractional RF microneedling devices are invasive (they penetrate the skin) and typically require 510(k) premarket notification as Class II devices in the US - so if a claim is made it must say 'cleared'. If no clearance exists, the device cannot be lawfully marketed in the US for those indications. - The listing makes therapeutic-style claims (remodels collagen and elastin, treats scars and stretch marks), which is exactly the type of claim that requires regulatory substantiation. **⚠️ FLAG - procurement verification required.** Before purchase, obtain from the supplier: (1) written confirmation of whether an FDA 510(k) clearance exists plus the number and cleared indication wording, (2) CE marking documentation to EU MDR 2017/745 or UKCA evidence, (3) a signed regulatory status letter on company letterhead, (4) IEC 60601-1 electrical safety certification, (5) needle-tip biocompatibility and sterility documentation (tips are invasive consumables), and (6) a written tip-supply commitment - because clearance-priced stock may be discontinued. **Business case:** This is the one device in the sample where the regulatory question is also a continuity question: buying a clearance-priced invasive device without a documented clearance number and a tip-supply guarantee is a double exposure - legal and operational. **Confidence:** Low - no FDA or equivalent regulatory information of any kind is present in the product data, so no status can be stated either way. **Evidence source:** Product listing `goldskin-fractional-radiofrequency-for-face-and-body` (id=685), fields: title, lede, fda_key, fda_label, fda_tone, what_it_is, how_it_works (all regulatory fields empty).

The listing describes the two treatment modes, the tip count and the minimal-recovery positioning but publishes no session schedule. Use the standard fractional RF microneedling protocol for this device class and confirm exact parameters with the manufacturer: a course of 3-4 sessions spaced 4-6 weeks apart for facial wrinkles, laxity and scars, then maintenance every 6-12 months. Stretch marks and body indications typically require 4-6 sessions. **Key points:** - Course: 3-4 sessions at 4-6 week intervals is standard for facial fractional RF microneedling; body treatments (stretch marks) generally need 4-6. - Mode selection: non-invasive RF matrix mode suits clients wanting tightening with essentially no downtime; the invasive RF microneedling mode is used where needle-depth remodelling is required. - Downtime: the listing claims minimal recovery; expect 1-3 days of redness and micro-crusting after invasive-mode treatment, so book it away from client events. - Maintenance: one session every 6-12 months keeps the collagen-remodelling result. - Consumable: needle tips are disposable - one per client, and the running cost should be modelled into the price per session. **Business case:** Fractional RF microneedling justifies the highest per-session price in this category because it addresses wrinkles, scars and laxity simultaneously; a course-and-maintenance model converts each client into roughly two bookings per year indefinitely. **Confidence:** Medium - the modes, tip count and minimal-recovery claim are product-documented; the session counts and intervals are standard clinical practice for fractional RF microneedling rather than published device specifications. **Evidence source:** Product listing `goldskin-fractional-radiofrequency-for-face-and-body` (id=685), fields: lede, what_it_is, how_it_works, who_for.

Yes - the listing states the Goldskin Fractional Micro Needle RF is suitable for all skin types and tones. This is the only explicit all-skin-types-and-tones claim in the sample of ten devices reviewed, and it makes the device unusually flexible for clinics with diverse client populations. The claim is a manufacturer statement in the `who_for` field; the record carries no clinical data or Fitzpatrick parameters behind it. **Key points:** - Stated suitability: all skin types and tones, including clients under 50 with oily or acne-prone skin and older or thinner skin (source: `who_for`). - Indication fit across skin types: the same listing names wrinkles, scars, stretch marks, enlarged pores and laxity as its treatment targets. - For Fitzpatrick IV-VI clients, a blanket all-types claim does not remove the need for conservative parameters on an invasive (needle-penetrating) device: start at lower needle depth and energy, and photograph the baseline. - Screen for and document: isotretinoin use within 6 months, active acne or infection in the treatment area, anticoagulants, keloid tendency, pregnancy, and metal implants or pacemakers (RF contraindication). - Needle tips are invasive consumables - confirm sterility documentation and one-tip-per-client practice. **Business case:** An all-skin-types claim lets a clinic market one fractional RF service to the entire client base rather than maintaining separate protocols and pricing tiers by Fitzpatrick type, which simplifies both marketing and the training requirement for new operators. **Confidence:** High for the existence of the all-skin-types-and-tones statement in the product record; Medium for treating it as clinically adequate guidance, since it is a manufacturer marketing statement without published Fitzpatrick parameters or clinical data. **Evidence source:** Product listing `goldskin-fractional-radiofrequency-for-face-and-body` (id=685), fields: lede, what_it_is, how_it_works, who_for ('It is suitable for all skin types and tones...').